← FDA Drug Approvals (Drugs@FDA)
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CADILA · Approved 2019-02-11
Drug application
- FDA Application #
ANDA208358- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TRIAMTERENE AND HYDROCHLOROTHIAZIDE
- Generic name
- TRIAMTERENE AND HYDROCHLOROTHIAZIDE
- Active ingredients
- HYDROCHLOROTHIAZIDE; TRIAMTERENE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CADILA
- Manufacturer
- Zydus Lifesciences Limited
- First approval
- 2019-02-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown